KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Total Current Liabilities (2016 - 2026)

Staar Surgical (STAA) has disclosed Total Current Liabilities for 17 consecutive years, with $68.5 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities fell 2.56% year-over-year to $68.5 million, compared with a TTM value of $68.5 million through Jan 2026, down 2.56%, and an annual FY2026 reading of $68.5 million, down 2.56% over the prior year.
  • Total Current Liabilities was $68.5 million for Q1 2026 at Staar Surgical, up from $61.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $70.3 million in Q4 2024 and bottomed at $41.2 million in Q2 2022.
  • Average Total Current Liabilities over 5 years is $58.2 million, with a median of $60.4 million recorded in 2025.
  • The sharpest move saw Total Current Liabilities skyrocketed 33.17% in 2024, then dropped 10.49% in 2025.
  • Year by year, Total Current Liabilities stood at $51.7 million in 2022, then grew by 25.76% to $65.0 million in 2023, then increased by 8.1% to $70.3 million in 2024, then dropped by 12.33% to $61.6 million in 2025, then grew by 11.14% to $68.5 million in 2026.
  • Business Quant data shows Total Current Liabilities for STAA at $68.5 million in Q1 2026, $61.6 million in Q3 2025, and $59.2 million in Q2 2025.